Since MCT1 is a key transporter for lactate uptake by endothelial cells, a study has employed CHC and siRNA to inhibit MCT1, thereby effectively suppressing lactate-induced tumor angiogenesis. This evidence concerns the gene SLC16A1 and neoplasm.